MiMedx Group, Inc.
(NASDAQ : MDXG)

( )
MDXG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -1.74%554.791.0%$842.68m
DHRDanaher Corp. -1.66%270.020.7%$719.70m
MDTMedtronic Plc -1.00%78.460.6%$661.61m
ABMDABIOMED, Inc. -0.32%376.253.3%$639.90m
ABTAbbott Laboratories -1.23%106.580.8%$547.36m
ISRGIntuitive Surgical, Inc. -2.36%268.000.8%$531.40m
BDXBecton, Dickinson & Co. -0.27%250.311.0%$477.33m
EWEdwards Lifesciences Corp. -1.99%76.000.4%$434.05m
SYKStryker Corp. -1.59%237.001.3%$347.57m
DXCMDexCom, Inc. -2.44%115.151.9%$297.30m
BSXBoston Scientific Corp. -0.87%45.761.0%$272.18m
BAXBaxter International, Inc. -0.33%52.201.8%$252.36m
AAgilent Technologies, Inc. 0.08%156.121.7%$228.96m
WSTWest Pharmaceutical Services, Inc. -0.06%242.021.6%$201.42m
ALGNAlign Technology, Inc. -3.33%195.056.4%$198.67m

Company Profile

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.